VAZRA-AQ Injection

Product Description

VAZRA-AQ contains diclofenac sodium in an injectable dosage form. Diclofenac is an NSAID used for rapid analgesic and anti-inflammatory action in selected acute conditions where injectable treatment is clinically appropriate.

Administration must be performed by qualified healthcare personnel according to prescribing information. Injectable diclofenac carries important gastrointestinal, renal, cardiovascular and injection-related risks and is not for self-administration.

Composition / Nutritional Information

• Diclofenac Sodium IP — 75 mg per 1 ml
• Water for Injection IP — q.s.

Indications / Intended Support

• Acute musculoskeletal pain
• Post-operative pain
• Renal colic
• Trauma-related painful conditions
• Severe inflammatory pain when clinically indicated

Key Product Features

• Injectable route for acute-care settings
• NSAID analgesic and anti-inflammatory action
• Suitable for clinician-directed hospital/clinic use
• Defined 75 mg/ml strength